Recent advances in tumor immunotherapy based on NK cells

Area of Science:

• Oncology
• Immunology
• Translational Medicine

Background:

• Immunotherapy is the fourth pillar of cancer treatment.
• Natural Killer (NK) cells are innate cytotoxic lymphocytes with MHC-independent antitumor properties, suitable for off-the-shelf therapies.
• Genetic engineering can enhance NK cell functions like activation, proliferation, and tumor homing.

Purpose of the Study:

• To provide a comprehensive overview of NK cell biology and antitumor mechanisms.
• To review current NK cell-based tumor immunotherapy strategies.
• To identify challenges and future directions for NK cell immunotherapy.

Main Methods:

• Review of biological characteristics of NK cells.
• Analysis of NK cell antitumor mechanisms.
• Evaluation of genetic engineering strategies for NK cells.
• Comparison with CAR-T cell therapy.
• Identification of challenges in clinical application.

Main Results:

• NK cells offer unique antitumor properties and potential for off-the-shelf products.
• Engineered NK cells show enhanced therapeutic potential.
• NK cell immunotherapy demonstrates better safety and tolerability than CAR-T therapy.
• Key challenges include in vitro expansion, in vivo persistence, CAR-NK transduction efficiency, and tumor microenvironment suppression.

Conclusions:

• NK cell-based immunotherapy is a rapidly advancing field with significant potential.
• Overcoming current challenges is crucial for maximizing clinical efficacy.
• Further research is needed to optimize NK cell therapies for cancer treatment.